TCL Archive Intarferon Results Promising, ACS Says, And commits Another $3.4 Million February 22, 1980
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive NCI Community Cancer Centers RFP Issued; Advisors Criticize Project Structure. November 10, 2006
TCL Archive Funding opportunities: ASCO breast cancer research award; Lustgarten Foundation prostate cancer research award; NCI program announcements available. March 5, 2004